REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study
Clinical trial NCT06041386 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06041386
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2025-01-31
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.